Crowdonomics
All companies
BIOPHYSICAL THERAPEUTICS, INC. logo

BIOPHYSICAL THERAPEUTICS, INC.

Operating

Biophysical Therapeutics, Inc.

Healthcare · Biotech · Wilmington, DE · Founded 2022

Immigrant-foundedVeteran-founded
Visit website111 followers on WeFunder · as of Sep 10, 2026

Trying to develop a drug to slow aging

Valuation cap ⓘ
$8.0M
As of Jul 2026 · from Reg CF Offering (2026) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$174,290
Across 2 rounds since 2023

Financials

FY2021–FY2025 (no data for FY2023) · from SEC filings · hover any figure for its source
$0
2021
$0
2022
2023no data
$0
−$83K
2024
$0
−$67K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
$0
$0
-$82,802
-$66,936
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$90
$52,288
$40,500
Accounts receivable
$0
$0
$0
$0
Total assets
$0
$90
$52,288
$40,500
Short-term debt
$0
$0
$0
$0
Long-term debt
$0
$0
$0
$0
Total liabilities
$0
$0
$0
$0
Other
Headcount
—
1
—
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$6.5M
Valuation cap
$8.0M
Valuation cap
BIOPHYSICAL THERAPEUTICS, INC. Future Equity SAFE 1
Reg CF Offering (2026)

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Reg CF Offering (2026)OpenReg CF · SAFE · via WeFunder
Raised $114.7K / $124KInvestors 56Valuation cap $8M
BIOPHYSICAL THERAPEUTICS, INC. Future Equity SAFE 1ClosedReg CF · SAFE · via WeFunder
Raised $59.6K / $124KInvestors 119Valuation cap $6.5M

Team

3 people
Dr. Michael ForrestFounder
Drug Inventor | CEO

Cambridge University biochemistry graduate with a Ph.D. in computer science. A computational biology authority and drug inventor.

Professor Bruno Conti
Advisor

Professor Emeritus at The Scripps Research Institute. Where he led a team that extended lifespan in mice, which was published in the prestigious scientific journal Science.

Professor George Church
Advisor

Tenured faculty at Harvard Medical School. One of the most famous scientists in the world and arguably the biggest name in biotech.

Names and titles as disclosed on SEC Form C, WeFunder. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 1 of 3 annual reports (FY2023–FY2025)

119 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 9 filings on EDGAR
  • Form CJul 7, 20260001980213-26-000004
    EDGAR
  • Form C-TRMay 19, 20260001980213-26-000003
    EDGAR
  • Form C-ARMay 18, 20260001980213-26-000002
    EDGAR
  • Form C-UOct 21, 20240001670254-24-001010
    EDGAR
  • Form C-UOct 21, 20240001670254-24-001009
    EDGAR
  • Form C/ADec 20, 20230001670254-23-001170
    EDGAR
  • Form COct 17, 20230001670254-23-000971
    EDGAR
  • Form DAug 21, 20230001980213-23-000003
    EDGAR
Source: ManualCIK 0001980213

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.